Found: 19
Select item for more details and to access through your institution.
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 6, p. 760, doi. 10.1007/s10637-016-0385-0
- By:
- Publication type:
- Article
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01652
- By:
- Publication type:
- Article
Clinical Outcomes of Patients with Advanced Cancer and Pre‐Existing Autoimmune Diseases Treated with Anti‐Programmed Death‐1 Immunotherapy: A Real‐World Transverse Study.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e327, doi. 10.1634/theoncologist.2018-0618
- By:
- Publication type:
- Article
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1479-5876-12-116
- By:
- Publication type:
- Article
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Irinotecan-based chemotherapy in extrapulmonary neuroendocrine carcinomas: survival and safety data from a multicentric Italian experience.
- Published in:
- Endocrine (1355008X), 2021, v. 74, n. 3, p. 707, doi. 10.1007/s12020-021-02813-y
- By:
- Publication type:
- Article
Temozolomide alone or in combination with capecitabine in patients with advanced neuroendocrine neoplasms: an Italian multicenter real-world analysis.
- Published in:
- Endocrine (1355008X), 2021, v. 72, n. 1, p. 268, doi. 10.1007/s12020-020-02421-2
- By:
- Publication type:
- Article
TGF-β mRNA levels in circulating extracellular vesicles are associated with response to anti-PD1 treatment in metastatic melanoma.
- Published in:
- Frontiers in Molecular Biosciences, 2024, p. 01, doi. 10.3389/fmolb.2024.1288677
- By:
- Publication type:
- Article
Effect of Age on Melanoma Risk, Prognosis and Treatment Response.
- Published in:
- Acta Dermato-Venereologica, 2018, v. 98, n. 7, p. 624, doi. 10.2340/00015555-2944
- By:
- Publication type:
- Article
Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 24, p. 3923, doi. 10.1002/cncr.28953
- By:
- Publication type:
- Article
Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 months.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0067-4
- By:
- Publication type:
- Article
Comparison Between First Line Target Therapy and Immunotherapy in Different Prognostic Categories of BRAF Mutant Metastatic Melanoma Patients: An Italian Melanoma Intergroup Study.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.917999
- By:
- Publication type:
- Article
The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN Study.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 1980, doi. 10.3390/cancers15071980
- By:
- Publication type:
- Article
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 2, p. e220290, doi. 10.1001/jamanetworkopen.2022.0290
- By:
- Publication type:
- Article
Efficacy and Safety of Lanreotide Autogel and Temozolomide Combination Therapy in Progressive Thoracic Neuroendocrine Tumors (Carcinoid): Results from the Phase 2 ATLANT Study.
- Published in:
- Neuroendocrinology, 2023, v. 113, n. 3, p. 332, doi. 10.1159/000526811
- By:
- Publication type:
- Article
Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors.
- Published in:
- Neuroendocrinology, 2016, v. 103, n. 6, p. 806, doi. 10.1159/000444087
- By:
- Publication type:
- Article
Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2014, v. 33, n. 1, p. 1, doi. 10.1186/1756-9966-33-30
- By:
- Publication type:
- Article
Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy).
- Published in:
- Targeted Oncology, 2021, v. 16, n. 6, p. 789, doi. 10.1007/s11523-021-00850-1
- By:
- Publication type:
- Article
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC.
- Published in:
- 2018
- By:
- Publication type:
- journal article